Obermatt

Metropolis Healthcare

NSI:METROPOLIS · INE112L01020
Health Care Providers & ServicesMedium

360

90
EV / EBIT29
Price / Owner Earnings19
Owner Earnings Yield58
Dividend Yield51
Price/Sales17
EV / Gross Profit25
Price/Book14
Return on Capital86
Cash Return on Capital92
Return on Equity76
EBIT Margin94
Gross Profitability91
Cash Conversion41
Owner Earnings Margin96
Sales growth84
Profit Growth34
Long-Term EPS Growth70
Reinvestment84
Price momentum85
Debt load61
Refinancing43
Debt Payback74
Liquidity56
Analyst ratings40
Opinion Changes50
Price Target Upside38
Market mood50
Value Creation20/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Metropolis Healthcare generates returns well above its cost of capital, the foundation of durable shareholder value.

Based on 3/5 components.

Profile

CountryIndia
IndustryHealth Care Providers & Services
SizeMedium
TypePublic Company
ExchangeNSEI
Founded2000
Employees1,759
ISININE112L01020
Last UpdateApr 2, 2026
Index & Theme
GeneticsHealth DiagnosticsImmunologyNephrologyHematologyNeurologyOncologyHealth CareHospitalWellness

Description

Metropolis Healthcare Limited provides pathology services, focusing on diagnostic testing and laboratory services. It operates with a commitment to excellence in healthcare, ensuring that patients receive accurate and timely results. Business Segmen…

Analysis

Beloved champion

Metropolis Healthcare Limited is a beloved champion: its quality is genuine, and the market already prices it as exceptional. One caution: reported profits have recently run ahead of actual cash, which we track closely.

The price is expensive. You pay 35.4× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 14% yearly growth; analysts expect 28%. The price, in other words, assumes less than the experts do.

The trajectory is solid and the balance sheet is sturdy. The company scores 20/20 on our value-creation score: strong value creator.

What to watch: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
64
2023202420252026

All-time high

75

Mar 2026

All-time low

12

Jan 2024

Average rank

44

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
17
28
19
5
Price/Earnings
14
26
10
3
Price/Book
14
16
19
5
Dividend Yield
51
28
39
46
Value (overall)
17
23
12
5

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Metropolis Healthcare with its peers
Dr. Lal PathLabs
NSI:LALPATHLAB
62
CountryIndia
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Bumrungrad Hospital
SET:BH
72
CountryThailand
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Max Healthcare Institute
NSI:MAXHEALTH
58
CountryIndia
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Sikarin
SET:SKR
57
CountryThailand
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
IHH Healthcare
KLS:IHH
36
CountryMalaysia
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Fleury
SAO:FLRY3
95
CountryBrazil
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →